UC San Diego is conducting what is believed to be the largest research study yet of SARS-CoV-2 antibodies and the protection they impart against contracting COVID-19. The ZAP COVID-19 is a two-year study designed to enroll up to 20,000 volunteer participants.
Novel trial measured simulated driving performance of persons after cannabis use, revealing sharply differentiated levels of ability and perception of skills.
Transcranial magnetic stimulation offers hope for antidepressant-resistant psychiatric disorders at UC San Diego Health.
National Institutes of Health establishes Microbiome and Metagenomics Center at UC San Diego, part of new effort to predict individual responses to food and inform personalized nutrition recommendations.
UC San Diego Herbert Wertheim School of Public Health study reports that the more steps taken, and the more intense, the lower the risk of Type 2 diabetes among women 65 and older.
Amplifying the voices and messages of marginalized communities. Showing up for others with care and intention. Taking the time to listen and learn new perspectives. There are many ways to be an ally, and at the upcoming Triton Leaders Conference, UC San Diego invites attendees to continue advancing this work to build a more equitable and inclusive world.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
